You are here: Home 
Categories Investigative Urology
Categories Investigative Urology XPD Asp312Asn polymorphism is a risk factor for prostate cancer - Abstract
XPD Asp312Asn polymorphism is a risk factor for prostate cancer - Abstract
Published on 22 August 2012
PURPOSE:The association between Asp312Asn and Lys751Gln polymorphisms of Xeroderma pigmentosum Group D (XPD) and prostate cancer risk are still inconclusive.
To read more, a FREE Urotoday registration is required. Click here to register or login above.To read UIJ content, a separate subscription is required.
Tags: